175 related articles for article (PubMed ID: 19390187)
1. Preradiation chemotherapy with ACNU-CDDP in patients with newly diagnosed glioblastoma: a retrospective analysis.
Han JH; Park CK; Lee SH; Kim CY; Kim DW; Paek SH; Kim DG; Heo DS; Kim IH; Jung HW
Chemotherapy; 2009; 55(3):145-54. PubMed ID: 19390187
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the clinical efficacy of temozolomide (TMZ) versus nimustine (ACNU)-based chemotherapy in newly diagnosed glioblastoma.
Wang Y; Chen X; Zhang Z; Li S; Chen B; Wu C; Wang L; Zhang X; Wang J; Chen L; Jiang T
Neurosurg Rev; 2014 Jan; 37(1):73-8. PubMed ID: 23912878
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial.
Kim IH; Park CK; Heo DS; Kim CY; Rhee CH; Nam DH; Lee SH; Han JH; Lee SH; Kim TM; Kim DW; Kim JE; Paek SH; Kim DG; Kim IA; Kim YJ; Kim JH; Park BJ; Jung HW
J Neurooncol; 2011 Jul; 103(3):595-602. PubMed ID: 21052775
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305).
Shibui S; Narita Y; Mizusawa J; Beppu T; Ogasawara K; Sawamura Y; Kobayashi H; Nishikawa R; Mishima K; Muragaki Y; Maruyama T; Kuratsu J; Nakamura H; Kochi M; Minamida Y; Yamaki T; Kumabe T; Tominaga T; Kayama T; Sakurada K; Nagane M; Kobayashi K; Nakamura H; Ito T; Yazaki T; Sasaki H; Tanaka K; Takahashi H; Asai A; Todo T; Wakabayashi T; Takahashi J; Takano S; Fujimaki T; Sumi M; Miyakita Y; Nakazato Y; Sato A; Fukuda H; Nomura K
Cancer Chemother Pharmacol; 2013 Feb; 71(2):511-21. PubMed ID: 23228988
[TBL] [Abstract][Full Text] [Related]
5. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
Weller M; Müller B; Koch R; Bamberg M; Krauseneck P;
J Clin Oncol; 2003 Sep; 21(17):3276-84. PubMed ID: 12947063
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of chemotherapy with ACNU plus cisplatin followed by cranial irradiation in patients with newly diagnosed glioblastoma multiforme.
Choi IS; Lee SH; Kim TY; Bang JS; Paek SH; Kim S; Kim IH; Heo DS; Bang YJ; Kim DG; Jung HW; Kim NK
J Neurooncol; 2002 Nov; 60(2):171-6. PubMed ID: 12635665
[TBL] [Abstract][Full Text] [Related]
8. ACNU-cisplatin continuous infusion chemotherapy as salvage therapy for recurrent glioblastomas: phase II study.
Gwak HS; Youn SM; Kwon AH; Lee SH; Kim JH; Rhee CH
J Neurooncol; 2005 Nov; 75(2):173-80. PubMed ID: 16132508
[TBL] [Abstract][Full Text] [Related]
9. Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy.
Affronti ML; Heery CR; Herndon JE; Rich JN; Reardon DA; Desjardins A; Vredenburgh JJ; Friedman AH; Bigner DD; Friedman HS
Cancer; 2009 Aug; 115(15):3501-11. PubMed ID: 19514083
[TBL] [Abstract][Full Text] [Related]
10. Radiation therapy combined with radiosensitizing agents for cerebral glioblastoma in adults.
Matsutani M; Nakamura O; Nakamura M; Nagashima T; Asai A; Fujimaki T; Tanaka H; Ueki K; Tanaka Y
J Neurooncol; 1994; 19(3):227-37. PubMed ID: 7807173
[TBL] [Abstract][Full Text] [Related]
11. Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.
Lipani JD; Jackson PS; Soltys SG; Sato K; Adler JR
Technol Cancer Res Treat; 2008 Jun; 7(3):249-55. PubMed ID: 18473497
[TBL] [Abstract][Full Text] [Related]
12. Proton beam therapy with concurrent chemotherapy for glioblastoma multiforme: comparison of nimustine hydrochloride and temozolomide.
Mizumoto M; Yamamoto T; Ishikawa E; Matsuda M; Takano S; Ishikawa H; Okumura T; Sakurai H; Matsumura A; Tsuboi K
J Neurooncol; 2016 Oct; 130(1):165-170. PubMed ID: 27535747
[TBL] [Abstract][Full Text] [Related]
13. Postoperative radiotherapy of glioblastoma multiforme: analysis and critical assessment of different treatment strategies and predictive factors.
Piroth MD; Gagel B; Pinkawa M; Stanzel S; Asadpour B; Eble MJ
Strahlenther Onkol; 2007 Dec; 183(12):695-702. PubMed ID: 18040615
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.
Mirimanoff RO; Gorlia T; Mason W; Van den Bent MJ; Kortmann RD; Fisher B; Reni M; Brandes AA; Curschmann J; Villa S; Cairncross G; Allgeier A; Lacombe D; Stupp R
J Clin Oncol; 2006 Jun; 24(16):2563-9. PubMed ID: 16735709
[TBL] [Abstract][Full Text] [Related]
15. [Combined postoperative radiotherapy and chemotherapy for malignant gliomas].
Aida T; Sugimoto S; Tokuda K; Abe H; Ikoda T; Itoh T; Ueno K; Kashiwaba T; Kaneko S; Kawamoto T
Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):952-9. PubMed ID: 2167916
[TBL] [Abstract][Full Text] [Related]
16. Nimustine (ACNU) plus teniposide (VM26) in recurrent glioblastoma.
Glas M; Hundsberger T; Stuplich M; Wiewrodt D; Kurzwelly D; Nguyen-Huu B; Rasch K; Herrlinger U
Oncology; 2009; 76(3):184-9. PubMed ID: 19218824
[TBL] [Abstract][Full Text] [Related]
17. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
[TBL] [Abstract][Full Text] [Related]
18. Randomized study of postoperative radiotherapy and simultaneous temozolomide without adjuvant chemotherapy for glioblastoma.
Kocher M; Frommolt P; Borberg SK; Rühl U; Steingräber M; Niewald M; Staar S; Stuschke M; Becker G; Fischedick AR; Herfarth K; Grauthoff H; Müller RP
Strahlenther Onkol; 2008 Nov; 184(11):572-9. PubMed ID: 19016015
[TBL] [Abstract][Full Text] [Related]
19. Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme.
Athanassiou H; Synodinou M; Maragoudakis E; Paraskevaidis M; Verigos C; Misailidou D; Antonadou D; Saris G; Beroukas K; Karageorgis P
J Clin Oncol; 2005 Apr; 23(10):2372-7. PubMed ID: 15800329
[TBL] [Abstract][Full Text] [Related]
20. ACNU-based chemotherapy for recurrent glioma in the temozolomide era.
Happold C; Roth P; Wick W; Steinbach JP; Linnebank M; Weller M; Eisele G
J Neurooncol; 2009 Mar; 92(1):45-8. PubMed ID: 18987781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
